Acadia Healthcare Company Inc (ACHC)
Cash ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 76,305 | 100,073 | 97,649 | 133,813 | 378,697 |
| Short-term investments | US$ in thousands | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 577,919 | 885,781 | 388,326 | 404,861 | 1,308,180 |
| Cash ratio | 0.13 | 0.11 | 0.25 | 0.33 | 0.29 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($76,305K
+ $—K)
÷ $577,919K
= 0.13
The cash ratio for Acadia Healthcare Company Inc has fluctuated over the years based on the provided data. As of December 31, 2020, the cash ratio was 0.29, indicating that the company had $0.29 in cash and cash equivalents for every $1 of current liabilities. This ratio increased to 0.33 by December 31, 2021, suggesting an improvement in the company's ability to cover its short-term obligations with its available cash.
However, the cash ratio declined to 0.25 by December 31, 2022, and decreased further to 0.11 by December 31, 2023. These lower ratios may raise concerns about Acadia Healthcare's liquidity position and its ability to meet immediate financial obligations using its existing cash resources.
By December 31, 2024, the cash ratio slightly improved to 0.13, but it still remained relatively low compared to previous years. It is important for investors and stakeholders to monitor Acadia Healthcare's cash ratio closely, as a low ratio could indicate potential liquidity issues and may require the company to assess its cash management practices and possibly seek additional funding sources to ensure financial stability.
Peer comparison
Dec 31, 2024